Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics

globenewswire.com
PFE NVS SNY AZN

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

globenewswire.com
NVS

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

globenewswire.com
NVS

Lincotek ernennt neuen Global General Manager für seine Medizinabteilung

businesswire.com
JBL PFE BAX NVS GSK JNJ

Lincotek nomme un nouveau directeur général mondial pour sa division médicale

businesswire.com
PFE NVS GSK JNJ JBL

Lincotek ernennt neuen Global General Manager für seine Medizinabteilung

businesswire.com
PFE BAX NVS GSK JNJ

Sidewinder Therapeutics Announces $137 Million Series B Financing to Advance Precision Bispecific ADCs into Clinical Development for Cancer

businesswire.com
NVS

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

globenewswire.com
NVS

Lincotek Appoints New Global General Manager for Its Medical Division

businesswire.com
PFE BAX NVS GSK JNJ JBL

Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR

globenewswire.com
NVS LLY